AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
SILODOSIN
32 registrations across 7 African markets— 30 active
Markets with SILODOSIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SILOTRIF 8 Capsule | 🇰🇪Kenya | MSN Laboratories Private Limited12 | active | Apr 2031 |
| Silorap Capsule 4 mg** Capsule | 🇳🇬Nigeria | Getz Pharma Nigeria Limited | active | Jul 2030 |
| Siloxin Capsules 4mg Capsule | 🇰🇪Kenya | GETZ PHARMA (PRIVATE) LIMITED | active | Apr 2030 |
| Siloxin Capsules 8mg Capsule | 🇰🇪Kenya | GETZ PHARMA (PRIVATE) LIMITED | active | Apr 2030 |
| Silotrif 8 mg Capsule** Capsule | 🇳🇬Nigeria | Phillips Pharmaceuticals (Nigeria) Limited | active | Aug 2029 |
| SILODOSIN 8 UNICORN | 🇿🇦South Africa | Unicorn Pharmaceuticals (Pty) Ltd | active | Aug 2029 |
| SILODOSIN 4 UNICORN | 🇿🇦South Africa | Unicorn Pharmaceuticals (Pty) Ltd | active | Aug 2029 |
| Silorap Capsule 8 mg** Capsule | 🇳🇬Nigeria | Getz Pharma Nigeria Limited | active | Jun 2029 |
| SILPROSIA 4 | 🇿🇦South Africa | LeBasi Pharmaceuticals (Pty) Ltd | active | May 2029 |
| SILPROSIA 8 | 🇿🇦South Africa | LeBasi Pharmaceuticals (Pty) Ltd | active | May 2029 |
| SIPRODER 4 | 🇿🇦South Africa | Adcock Ingram Limited | active | May 2029 |
| Silotrif 4 mg Capsule** Capsule | 🇳🇬Nigeria | Phillips Pharmaceuticals (Nigeria) Limited | active | Apr 2029 |
| MAKDOSIN 4 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| MAKDOSIN 8 mg | 🇿🇦South Africa | Macleods Pharmaceuticals SA (Pty) Ltd | active | Dec 2028 |
| SILDOS 4 mg | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | Oct 2028 |
| SILDOS 8 mg | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | Oct 2028 |
| SILOTRIF 4 CAPSULE | 🇿🇼Zimbabwe | MSN LABORATORIES PRIVATE LIMITED | active | Dec 2027 |
| URYDOS - 8 Capsule | 🇰🇪Kenya | Micro Labs Limited | active | Sept 2027 |
| URYDOS - 4 Capsule | 🇰🇪Kenya | Micro Labs Limited | active | Sept 2027 |
| URYDOS_4 4MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Mar 2023 |
| URYDOS_8 8MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Mar 2023 |
| RAPFLO 4 mg | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| RAPFLO 8 mg | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| SILODOSIN ORAL SOLID
ORDINARY OTHER
CAPSULES | 🇺🇬Uganda | MICRO LABS LIMITED | active | — |
| SILODOSIN ORAL SOLID
ORDINARY
OTHER
CAPSULES | 🇺🇬Uganda | MICRO LABS LIMITED | active | — |
| SILODOSIN ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | MSN LABORATORIES PRIVATE LIMITED, | active | — |
| SILODOSIN ORAL SOLID
ORDINARY
OTHER
CAPSULES | 🇺🇬Uganda | MICRO LABS LIMITED | active | — |
| Urydos-4 Capsules | 🇹🇿Tanzania | Micro Labs Limited | active | — |
| Urydos-8 Capsules | 🇹🇿Tanzania | Micro Labs Limited | active | — |
| Flopadex Capsules | 🇹🇿Tanzania | EVA Pharma for Pharmaceuticals and Medical Appliances | active | — |
| SILODOSIN ORAL SOLID
ORDINARY OTHER
CAPSULES | 🇺🇬Uganda | MICRO LABS LIMITED | active | — |
| SILODOSIN ORAL SOLID
ORDINARY
CAPSULES | 🇺🇬Uganda | MSN LABORATORIES PRIVATE LIMITED, | active | — |
SILODOSIN in Africa — Regulatory Overview
SILODOSIN is registered across 7 African markets with 32 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Kenya, Nigeria and 3 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 32 registrations, 30 (94%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.